Multi-center MRD Registry for Inflammatory Breast Cancer
Recruiting · NCT06966050 · Observational (researchers observe without assigning treatment) · Lead sponsor: M.D. Anderson Cancer Center
View the official record on ClinicalTrials.gov →Interventions studied
Quality-of-life Questionnaire
What this trial is about
To collect data from participants with IBC who may have had MRD testing and may have surgery in the future.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Female or males ≥18 years of age with the ability to understand and sign a written
- Participants who have a clinical diagnosis of stage III or IV inflammatory breast cancer (IBC).
- Participants who are planning to have or already completed a minimum of one blood draw for Signatera testing, for which the result and clinical data can be deposited into the study database.
- Participants must be within eight months of diagnosis and have not undergone breast surgery for this diagnosis of breast cancer.
- Participants must be English-speaking.
Where it is running
1 location listed across 1 US state.
- MD Anderson Cancer Center - Houston, Texas, United States